Dr. Paul August, an AcuraStem co-founder, has held key scientific and leadership roles for over 20 years with the global pharmaceutical company Sanofi. Dr. August began his Sanofi career in 1998 at the Hoechst-Ariad Genomics Center in Cambridge, Massachusetts. In 2010, he relocated to the Sanofi R&D site in Tucson, Arizona to lead the US Early to Candidate Unit. More recently Dr. August served as the VP of Genetically Defined Disease Biology at Agios Pharmaceuticals. Dr. August’s research has been particularly focused on developing disease-relevant, human-stem-cell-derived models. Dr. August is presently the CSO at ReviR Therapeutics.